March 08, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |
Biotechnology

Is the Patent Eligibility Act a Panacea for Claims to Diagnostics? |

By Newsroom
Last updated: April 5, 2025
1 Min Read
Share


On January 23, the Subcommittee on Intellectual Property held a hearing in which the members of the committee heard testimony about the Patent Eligibility Restoration Act (PERA) introduced by Senators Coons and Tillis. I have considered case law directed to s. 101 of 25 U.S.C. for more than a decade, and was hopeful that PERA could achieve its subtitled goal of “Restoring Clarity, Certainty, and Predictability to the U.S. Patent System”. The eight panelists had submitted comments that preceded the hearing, and the hearing was live streamed. The panelists were a blue ribbon group of patent attorneys who testified before the…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Nestlé sold treated water as ‘natural’ in alleged marketing fraud

Environmental Science
May 23, 2025

Mastering Cell Isolation and Exosome Enrichment

Techniques and applications using magnetic bead technology This eBook covers the techniques and applications using…

March 7, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers

On the heels of the rescission of the Fintiv guidance memorandum, the U.S. Patent and Trademark Office has again reshaped…

Biotechnology
April 5, 2025

Regents of the U. of Cal. v. Broad Inst. – “Just The Facts, Ma’am.” |

The central theme in this interference decision involving U.S. Pat. No. 8,697,359 is the amount and type of evidence required…

Biotechnology
June 6, 2025

Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute

In a pivotal ruling for patent damages and standard-essential patent (SEP) litigation, the Federal Circuit vacated a $300 million award…

Biotechnology
July 11, 2025

FDA Proposes Risk-Based and Remote Inspection Strategies in New Report

On May 5, 2021, the U.S. Food and Drug Administration (FDA) issued a much-anticipated report, “Resiliency Roadmap for FDA Inspectional…

Biotechnology
April 5, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

Mastering Cell Isolation and Exosome Enrichment
March 7, 2026
Isolation of RNA from organoids and spheroids
March 7, 2026
Webinar: Fundamentals of RNA Isolation
March 7, 2026
Outsourced Pharma Capabilities Update: Small Molecule Drug…
March 6, 2026

Life Science Magazines

Mastering Cell Isolation and Exosome Enrichment
March 7, 2026
Isolation of RNA from organoids and spheroids
March 7, 2026
Webinar: Fundamentals of RNA Isolation
March 7, 2026
Outsourced Pharma Capabilities Update: Small Molecule Drug…
March 6, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?